Effectiveness of the pre-Omicron COVID-19 vaccines against Omicron in reducing infection, hospitalization, severity, and mortality compared to Delta and other variants: A systematic review

Pradipta Paul(Weill Cornell Medical College in Qatar), Dalia Zakaria(Weill Cornell Medical College in Qatar), Zain Burney(Cleveland Clinic), Lina Yagan(Hospital of the University of Pennsylvania), Thanu Shree(Weill Cornell Medical College in Qatar), Reem Chamseddine(Weill Cornell Medical College in Qatar), Narjis Mhaimeed(Weill Cornell Medical College in Qatar), Dana Al‐Ali(Weill Cornell Medical College in Qatar), Muna Almasri(Weill Cornell Medical College in Qatar), Pratyaksha Sinha(Weill Cornell Medical College in Qatar), Abdallah Elshafeey(Weill Cornell Medical College in Qatar), Bushra Khanjar(Weill Cornell Medical College in Qatar), Jamal AlAnni(Cincinnati Children's Hospital Medical Center), Omar Khalil(Weill Cornell Medical College in Qatar), Nada Mhaimeed(Weill Cornell Medical College in Qatar), Ali Abdelati(Weill Cornell Medical College in Qatar), Mohammad Salameh(Mayo Clinic), Krishnadev V. Pillai(Weill Cornell Medical College in Qatar), Khalifa Bshesh(Weill Cornell Medical College in Qatar), Omar Mhaimeed(Johns Hopkins Hospital), Ahmed El-Naas(Weill Cornell Medical College in Qatar), Ibrahim Laswi(Weill Cornell Medical College in Qatar), Mohammad Bhatti(Weill Cornell Medical College in Qatar), Ahmed Aly(Weill Cornell Medical College in Qatar), Hasan Alroobi(Weill Cornell Medical College in Qatar), Omar Hamad(Weill Cornell Medical College in Qatar), Ashton D’Souza(Weill Cornell Medical College in Qatar)

Human Vaccines & Immunotherapeutics

January 2, 2023

Cited by 58

|Nature Reviews Cardiology|2021|792

|American Journal of Preventive Cardiology|2024|100

|Journal of Cellular and Molecular Medicine|2023|96

|Journal of Cellular and Molecular Medicine|2021|68

|The Journal of Clinical Pharmacology|2021|40

Related Papers